デフォルト表紙
市場調査レポート
商品コード
1622338

腫瘍栄養学市場規模、シェア、成長分析、がんタイプ別、栄養タイプ別、製剤別、流通チャネル別、エンドユーザー別、地域別 - 産業予測、2025~2032年

Oncology Nutrition Market Size, Share, Growth Analysis, By Cancer Type, By Nutrition Type, By Formulation, By Distribution Channel, By End-User, By Region - Industry Forecast 2025-2032


出版日
発行
SkyQuest
ページ情報
英文 219 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.96円
腫瘍栄養学市場規模、シェア、成長分析、がんタイプ別、栄養タイプ別、製剤別、流通チャネル別、エンドユーザー別、地域別 - 産業予測、2025~2032年
出版日: 2024年12月23日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

腫瘍栄養学市場規模は2023年に22億2,000万米ドルと評価され、2024年の24億2,000万米ドルから2032年には47億8,000万米ドルに成長し、予測期間(2025-2032年)のCAGRは8.9%で成長する見通しです。

世界の腫瘍栄養学市場は、がん罹患率の上昇と、がん治療における栄養の重要な役割に対する認識の高まりに後押しされ、力強い成長を遂げています。化学療法や放射線療法を受ける患者が増えるにつれて栄養不足が蔓延し、症状管理、体重維持、治療成績向上を目的とした専門的な食事サポートの必要性が高まっています。さらに、がんリスクの軽減や全体的な健康増進における栄養の影響力をめぐる意識の高まりが、市場の拡大をさらに後押ししています。主な利害関係者は研究開発に積極的に投資し、がん患者特有の栄養要件に合わせた革新的な製品やサービスを発表しており、この進化する市場情勢の中で成功するためのポジショニングを確立しています。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次データと一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターの分析

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場の魅力指数(2024年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析
  • 規制情勢
  • ケーススタディ

腫瘍栄養学市場規模:がんタイプ別

  • 市場概要
  • 消化器がん
  • 肺がん
  • 乳がん
  • 血液がん
  • 肝臓がん
  • その他

腫瘍栄養学市場規模:栄養タイプ別

  • 市場概要
  • 経腸栄養
    • 標準式
    • 疾患別の処方
  • 経腸栄養
    • 完全静脈栄養(TPN)
    • 末梢静脈栄養(PPN)

腫瘍栄養学市場規模:製剤別

  • 市場概要
  • 粉末
  • 液体
  • 錠剤

腫瘍栄養学市場規模:流通チャネル別

  • 市場概要
  • 病院薬局
  • 小売薬局
  • オンライン薬局

腫瘍栄養学市場規模:エンドユーザー別

  • 市場概要
  • 病院
  • 在宅ケア設定
  • 専門クリニック

腫瘍栄養学市場規模

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2024年)
  • 主な市場企業が採用した戦略
  • 市場の最近の動向
  • 企業の市場シェア分析(2024年)
  • 主要企業の企業プロファイル
    • 会社概要
    • 製品ポートフォリオ分析
    • セグメント別シェア分析
    • 収益の前年比比較(2022-2024)

主要企業プロファイル

  • Nestle Health Science(Switzerland)
  • Abbott Laboratories(USA)
  • Danone S.A.(France)
  • Fresenius Kabi AG(Germany)
  • B. Braun Melsungen AG(Germany)
  • Mead Johnson Nutrition Company(USA)
  • Hormel Foods Corporation(USA)
  • Meiji Holdings Co., Ltd.(Japan)
  • Victus, Inc.(USA)
  • Global Health Products, Inc.(USA)
  • Nutritional Medicinals, LLC(USA)
  • Kate Farms(USA)
  • Ajinomoto Co., Inc.(Japan)
  • Abbott Nutrition(USA)
  • Danone Nutricia(Netherlands)
  • Fresenius SE & Co. KGaA(Germany)
  • Baxter International Inc.(USA)
  • Nutritional Resources Inc.(USA)

結論と推奨事項

目次
Product Code: SQMIG35D2089

Oncology Nutrition Market size was valued at USD 2.22 Billion in 2023 and is poised to grow from USD 2.42 Billion in 2024 to USD 4.78 Billion by 2032, growing at a CAGR of 8.9% during the forecast period (2025-2032).

The global oncology nutrition market is experiencing robust growth, fueled by the escalating incidence of cancer and the increasing acknowledgment of nutrition's crucial role in cancer care. As more patients undergo chemotherapy and radiation therapy, nutritional deficiencies become prevalent, intensifying the need for specialized dietary support aimed at symptom management, weight maintenance, and better treatment outcomes. Moreover, the rising awareness surrounding nutrition's influence in mitigating cancer risks and enhancing overall health further propels market expansion. Key industry stakeholders are actively investing in research and development to launch innovative oncology nutrition products and services tailored to the unique nutritional requirements of cancer patients, positioning themselves for success in this evolving market landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Oncology Nutrition market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Oncology Nutrition Market Segmental Analysis

Global Oncology Nutrition Market is segmented by cancer type, nutrition type, formulation, distribution channel, end-user and region. Based on cancer type, the market is segmented into gastrointestinal cancer, lung cancer, breast cancer, blood cancer, liver cancer and others. Based on nutrition type, the market is segmented into enteral nutrition and parenteral nutrition. Based on formulation, the market is segmented into powder, liquid and tablet. Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies and online pharmacies. Based on end-user, the market is segmented into hospitals, homecare settings and specialty clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Oncology Nutrition Market

A significant driver of the oncology nutrition market is the rising global incidence of cancer, which necessitates effective supportive care. Cancer patients frequently face nutritional deficiencies and weight loss due to both the illness and the adverse effects of treatments like chemotherapy and radiation. As a result, oncology nutrition products and services are crucial for delivering essential nutrients, alleviating side effects, and enhancing the overall health and quality of life for those affected by cancer. The increasing awareness of the importance of nutrition therapy in comprehensive cancer care is fueling the demand for these specialized products and services, shaping the market's growth.

Restraints in the Oncology Nutrition Market

The oncology nutrition market faces a notable restraint due to the elevated costs associated with its products. These items are typically custom-made, incorporating specific nutrients tailored to the distinct dietary requirements of cancer patients. The expenses linked to research, development, manufacturing, and rigorous quality assurance increase their price beyond that of conventional nutritional supplements. Moreover, the necessity for personalized nutrition plans and tailored counseling services further escalates overall costs. Consequently, the high prices may hinder accessibility and affordability, particularly for patients in lower-income areas or those with limited financial resources. This financial barrier can significantly affect patient care and nutritional support.

Market Trends of the Oncology Nutrition Market

A prominent trend in the global Oncology Nutrition market is the increasing focus on personalized nutrition interventions tailored specifically for cancer patients. As the medical community recognizes the pivotal role of nutrition in cancer management and recovery, there is a surge in demand for customized nutritional support that aligns with each patient's individual needs. This approach leverages advanced diagnostic tools, including genetic profiling and biomarker analysis, to pinpoint specific nutritional deficiencies or requirements tied to individual cancer types and treatment protocols. By optimizing nutritional intake, enhancing immune function, and mitigating treatment-related side effects, personalized oncology nutrition aims to significantly improve patients' overall well-being and quality of life, reflecting the broader shift towards precision medicine in oncology care.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Regulatory Landscape
  • Case Studies

Global Oncology Nutrition Market Size by Cancer Type & CAGR (2025-2032)

  • Market Overview
  • Gastrointestinal Cancer
  • Lung Cancer
  • Breast Cancer
  • Blood Cancer
  • Liver Cancer
  • Others

Global Oncology Nutrition Market Size by Nutrition Type & CAGR (2025-2032)

  • Market Overview
  • Enteral Nutrition
    • Standard Formulas
    • Disease-Specific Formulas
  • Parenteral Nutrition
    • Total Parenteral Nutrition (TPN)
    • Peripheral Parenteral Nutrition (PPN)

Global Oncology Nutrition Market Size by Formulation & CAGR (2025-2032)

  • Market Overview
  • Powder
  • Liquid
  • Tablet

Global Oncology Nutrition Market Size by Distribution Channel & CAGR (2025-2032)

  • Market Overview
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Global Oncology Nutrition Market Size by End-User & CAGR (2025-2032)

  • Market Overview
  • Hospitals
  • Homecare Settings
  • Specialty Clinics

Global Oncology Nutrition Market Size & CAGR (2025-2032)

  • North America (Cancer Type, Nutrition Type, Formulation, Distribution Channel, End-User)
    • US
    • Canada
  • Europe (Cancer Type, Nutrition Type, Formulation, Distribution Channel, End-User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Cancer Type, Nutrition Type, Formulation, Distribution Channel, End-User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Cancer Type, Nutrition Type, Formulation, Distribution Channel, End-User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Cancer Type, Nutrition Type, Formulation, Distribution Channel, End-User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Nestle Health Science (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danone S.A. (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fresenius Kabi AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun Melsungen AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mead Johnson Nutrition Company (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hormel Foods Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Meiji Holdings Co., Ltd. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Victus, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Global Health Products, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nutritional Medicinals, LLC (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Kate Farms (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ajinomoto Co., Inc. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Nutrition (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danone Nutricia (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fresenius SE & Co. KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Baxter International Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nutritional Resources Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations